Herpesviruses: latency and reactivation – viral strategies and host response
Eight members of the Herpesviridae family commonly infect humans, and close to 100% of the adult population is infected with at least one of these. The five that cause the most health concerns are: herpes simplex virus (HSV) type 1 and 2, Epstein–Barr virus (EBV), cytomegalovirus (CMV), a...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2013-10-01
|
Series: | Journal of Oral Microbiology |
Subjects: | |
Online Access: | http://www.journaloforalmicrobiology.net/index.php/jom/article/download/22766/30742 |
id |
doaj-6a2d1dc15d614ae2984e698ad347288f |
---|---|
record_format |
Article |
spelling |
doaj-6a2d1dc15d614ae2984e698ad347288f2020-11-24T23:04:43ZengTaylor & Francis GroupJournal of Oral Microbiology2000-22972013-10-01501910.3402/jom.v5i0.22766Herpesviruses: latency and reactivation – viral strategies and host responseBjørn GrindeEight members of the Herpesviridae family commonly infect humans, and close to 100% of the adult population is infected with at least one of these. The five that cause the most health concerns are: herpes simplex virus (HSV) type 1 and 2, Epstein–Barr virus (EBV), cytomegalovirus (CMV), and varicella zoster virus (VZV). In addition, there are human herpes virus (HHV) types 6–8. The review starts by introducing possible viral strategies in general. The particular biology and host relationship of the various human herpesviruses, including their pathology, are examined subsequently. Factors that contribute to the maintenance of latency and reactivation of viral replication are discussed. There will be special reference to how these viruses exploit and contribute to pathology in the oral cavity. Reactivation does not necessarily imply clinical symptoms, as reflected in the asymptomatic shedding of EBV and CMV from oral mucosa. The immune response and the level of viral output are both important to the consequences experienced.www.journaloforalmicrobiology.net/index.php/jom/article/download/22766/30742herpes simplexEpstein–Barrcytomegalovirusvaricella zosterreemergenceimmune defenseviral pathologyoral cavity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bjørn Grinde |
spellingShingle |
Bjørn Grinde Herpesviruses: latency and reactivation – viral strategies and host response Journal of Oral Microbiology herpes simplex Epstein–Barr cytomegalovirus varicella zoster reemergence immune defense viral pathology oral cavity |
author_facet |
Bjørn Grinde |
author_sort |
Bjørn Grinde |
title |
Herpesviruses: latency and reactivation – viral strategies and host response |
title_short |
Herpesviruses: latency and reactivation – viral strategies and host response |
title_full |
Herpesviruses: latency and reactivation – viral strategies and host response |
title_fullStr |
Herpesviruses: latency and reactivation – viral strategies and host response |
title_full_unstemmed |
Herpesviruses: latency and reactivation – viral strategies and host response |
title_sort |
herpesviruses: latency and reactivation – viral strategies and host response |
publisher |
Taylor & Francis Group |
series |
Journal of Oral Microbiology |
issn |
2000-2297 |
publishDate |
2013-10-01 |
description |
Eight members of the Herpesviridae family commonly infect humans, and close to 100% of the adult population is infected with at least one of these. The five that cause the most health concerns are: herpes simplex virus (HSV) type 1 and 2, Epstein–Barr virus (EBV), cytomegalovirus (CMV), and varicella zoster virus (VZV). In addition, there are human herpes virus (HHV) types 6–8. The review starts by introducing possible viral strategies in general. The particular biology and host relationship of the various human herpesviruses, including their pathology, are examined subsequently. Factors that contribute to the maintenance of latency and reactivation of viral replication are discussed. There will be special reference to how these viruses exploit and contribute to pathology in the oral cavity. Reactivation does not necessarily imply clinical symptoms, as reflected in the asymptomatic shedding of EBV and CMV from oral mucosa. The immune response and the level of viral output are both important to the consequences experienced. |
topic |
herpes simplex Epstein–Barr cytomegalovirus varicella zoster reemergence immune defense viral pathology oral cavity |
url |
http://www.journaloforalmicrobiology.net/index.php/jom/article/download/22766/30742 |
work_keys_str_mv |
AT bjx00f8rngrinde herpesviruseslatencyandreactivationx2013viralstrategiesandhostresponse |
_version_ |
1725629012221362176 |